HERON ELAINE J 4
4 · BIOMARIN PHARMACEUTICAL INC · Filed May 17, 2023
Insider Transaction Report
Form 4
HERON ELAINE J
Director
Transactions
- Tax Payment
Common Stock
2023-05-12$93.93/sh−6,137$576,448→ 87,931 total - Exercise/Conversion
Common Stock
2023-05-12$67.81/sh+8,500$576,385→ 94,068 total - Exercise/Conversion
Stock Option (Right to Buy Common Stock)
2023-05-12−8,500→ 0 totalExercise: $67.81From: 2013-08-15Exp: 2023-05-14→ Common Stock (8,500 underlying)
Footnotes (1)
- [F1]Reflects the number of options outstanding after the transactions from this specific stock option grant.